Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND)
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Sponsor: SurModics, Inc.
A NA clinical study on Artery Disease, Peripheral and Femoropopliteal Artery Occlusion, this trial is completed. The trial is conducted by SurModics, Inc. and has accumulated 21 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
21 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Apr 2025 — Sep 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Apr 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 16 earlier versions
-
Jul 2023 — May 2024 [monthly]
Active Not Recruiting NA
-
Sep 2022 — Jul 2023 [monthly]
Active Not Recruiting NA
-
Apr 2022 — Sep 2022 [monthly]
Active Not Recruiting NA
-
Oct 2021 — Apr 2022 [monthly]
Active Not Recruiting NA
-
Apr 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Oct 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Recruiting NA
-
Jan 2019 — Sep 2019 [monthly]
Recruiting NA
-
Sep 2018 — Jan 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2018 — Mar 2018 [monthly]
Recruiting NA
-
Jan 2018 — Feb 2018 [monthly]
Recruiting NA
-
Dec 2017 — Jan 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2017 — Dec 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- SurModics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .